BACKGROUND AND PURPOSE: Diabetes is associated with the presence of moderate to large atherosclerotic carotid plaques. Previous carotid ultrasound studies have associated plaques with low echogenicity with a higher risk of cerebrovascular events. The aim of this study was to evaluate whether patients with type 2 diabetes have different plaque echogenicity than do nondiabetic subjects. METHODS: Forty-seven type 2 diabetic and 51 nondiabetic subjects with a carotid plaque in the right artery were included in this study. All patients were born in 1935 to 1936 and were participants in a population-based study. Carotid ultrasonography was performed and the risk factors for cardiovascular disease were determined. Plaque echogenicity was assessed quantitatively on B-mode ultrasound images by standardized gray-scale median values. RESULTS: Gray-scale median values were significantly lower, indicating more echolucent plaques, in patients with type 2 diabetes compared with nondiabetics (37.0+/-14.8 vs 45.5+/-15.4, P=0.007). Of the other risk factors studied, only triglycerides were significantly associated with the echogenicity of the plaque. CONCLUSIONS: Patients with type 2 diabetes have more echolucent plaques compared with nondiabetic subjects. This might be associated with the higher risk of cardiovascular events among diabetics.
BACKGROUND AND PURPOSE:Diabetes is associated with the presence of moderate to large atherosclerotic carotid plaques. Previous carotid ultrasound studies have associated plaques with low echogenicity with a higher risk of cerebrovascular events. The aim of this study was to evaluate whether patients with type 2 diabetes have different plaque echogenicity than do nondiabetic subjects. METHODS: Forty-seven type 2 diabetic and 51 nondiabetic subjects with a carotid plaque in the right artery were included in this study. All patients were born in 1935 to 1936 and were participants in a population-based study. Carotid ultrasonography was performed and the risk factors for cardiovascular disease were determined. Plaque echogenicity was assessed quantitatively on B-mode ultrasound images by standardized gray-scale median values. RESULTS: Gray-scale median values were significantly lower, indicating more echolucent plaques, in patients with type 2 diabetes compared with nondiabetics (37.0+/-14.8 vs 45.5+/-15.4, P=0.007). Of the other risk factors studied, only triglycerides were significantly associated with the echogenicity of the plaque. CONCLUSIONS:Patients with type 2 diabetes have more echolucent plaques compared with nondiabetic subjects. This might be associated with the higher risk of cardiovascular events among diabetics.
Authors: Jessika Andersson; Johan Sundström; Lisa Kurland; Thomas Gustavsson; Johannes Hulthe; Anders Elmgren; Kersti Zilmer; Mihkel Zilmer; Lars Lind Journal: Lipids Date: 2009-02-21 Impact factor: 1.880
Authors: Sumbal A Janjua; Pedro V Staziaki; Balint Szilveszter; Richard A P Takx; Thomas Mayrhofer; Orla Hennessy; Hamed A Emami; Jakob Park; Alexander Ivanov; Travis R Hallett; Michael T Lu; Javier M Romero; Steven K Grinspoon; Udo Hoffmann; Markella V Zanni; Tomas G Neilan Journal: Circ Cardiovasc Imaging Date: 2017-10 Impact factor: 7.792
Authors: Hanna Markstad; Andreas Edsfeldt; Ingrid Yao Mattison; Eva Bengtsson; Pratibha Singh; Michele Cavalera; Giuseppe Asciutto; Harry Björkbacka; Gunilla Nordin Fredrikson; Nuno Dias; Petr Volkov; Marju Orho-Melander; Jan Nilsson; Gunnar Engström; Isabel Gonçalves Journal: J Am Heart Assoc Date: 2019-02-19 Impact factor: 5.501
Authors: Isak Stenudd; Elias Sjödin; Emma Nyman; Per Wester; Elias Johansson; Christer Grönlund Journal: Int J Cardiovasc Imaging Date: 2020-03-06 Impact factor: 2.357